NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Endo Tools Therapeutics

Endo Tools Therapeutics

Private
BelgiumHealthcare & Life Scienceshttps://www.endotools.be/

Last Round

Series D

Jan 19, 2021

Total Funding Raised

$15.2M

Company Overview

Endo Tools Therapeutics is a medical device company that develops and markets innovative, minimally invasive endoscopic solutions for gastroenterologists.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic endoscopyendoscopic suturingmedical devicetriangulation platformincisionless surgerygastroenterology devicesendoscopic gastroplastyminimally invasive surgerytissue approximationNOTESnatural orifice surgerysurgical endoscopybariatric endoscopyendoluminal surgeryfull-thickness suturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endo Tools Therapeutics Comparables

Compare Endo Tools Therapeutics with similar companies based on industry and business-model similarity.

Endo Tools Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Endo Tools Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJan 19, 2021
Series CFeb 11, 2019
VC RoundSep 11, 2013

Key People

Founding team and executive leadership

Alexandre Chau

CEO

Executive Team

Nicolas De Bie

CFO

Executive Team

Endo Tools Therapeutics Investors

Notable investors and investment history

Endo Tools Therapeutics investors
InvestorRounds
Federal Holding and Investment CompanyVC Round, Series D, Series C
EpimedeSeries D, Series C
White FundSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2026

    Grew 26% QoQ from 23 to 29 employees.

  • Nov 10, 2024

    Monthly visitors increased 159% MoM.

Endo Tools Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Endo Tools Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endo Tools Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range29
Year Founded2008
Last FundingJan 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.